Thymidine rescue of high-dose methotrexate in humans

S. B. Howell, W. D. Ensminger, A. Krishan, E. Frei

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Thymidine rescue was administered following 63 courses of high dose methotrexate in 20 patients. In the first part of this study, the methotrexate was given as a 24-hr infusion and the dose was escalated from 0.14 to 8.54 g/sq m; in the second part, methotrexate was infused to maintain a serum concentration of 15 μM for 30, 36, or 40 hr. Thymidine rescue was started immediately after the end of the methotrexate infusions, and consisted of 8 g/sq m/day for 3 days or until serum methotrexate was below a toxic level. Mucositis and myelosuppression were the major toxicities. Neither was dose related. Serum methotrexate levels were proportional to the logarithm of the methotrexate dose. There was a mean 6-fold increase in thymidine concentration during rescue. However, thymidine levels prior to and during rescue were not related to the incidence of subsequent toxicity. Recovery of DNA synthesis in bone marrow cells was evident by nucleoside precursor incorporation at 24 hr after the start of rescue. Two of 16 evaluable patients achieved partial responses. This study indicates that thymidine is an effective rescue agent for high-dose methotrexate in humans.

Original languageEnglish
Pages (from-to)325-330
Number of pages6
JournalCancer Research
Volume38
Issue number2
StatePublished - Jan 1 1978
Externally publishedYes

Fingerprint

Methotrexate
Thymidine
Serum
Mucositis
Poisons
Nucleosides
Bone Marrow Cells
DNA
Incidence

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Howell, S. B., Ensminger, W. D., Krishan, A., & Frei, E. (1978). Thymidine rescue of high-dose methotrexate in humans. Cancer Research, 38(2), 325-330.

Thymidine rescue of high-dose methotrexate in humans. / Howell, S. B.; Ensminger, W. D.; Krishan, A.; Frei, E.

In: Cancer Research, Vol. 38, No. 2, 01.01.1978, p. 325-330.

Research output: Contribution to journalArticle

Howell, SB, Ensminger, WD, Krishan, A & Frei, E 1978, 'Thymidine rescue of high-dose methotrexate in humans', Cancer Research, vol. 38, no. 2, pp. 325-330.
Howell SB, Ensminger WD, Krishan A, Frei E. Thymidine rescue of high-dose methotrexate in humans. Cancer Research. 1978 Jan 1;38(2):325-330.
Howell, S. B. ; Ensminger, W. D. ; Krishan, A. ; Frei, E. / Thymidine rescue of high-dose methotrexate in humans. In: Cancer Research. 1978 ; Vol. 38, No. 2. pp. 325-330.
@article{35896b4a02b647eda5ae772cbb17daef,
title = "Thymidine rescue of high-dose methotrexate in humans",
abstract = "Thymidine rescue was administered following 63 courses of high dose methotrexate in 20 patients. In the first part of this study, the methotrexate was given as a 24-hr infusion and the dose was escalated from 0.14 to 8.54 g/sq m; in the second part, methotrexate was infused to maintain a serum concentration of 15 μM for 30, 36, or 40 hr. Thymidine rescue was started immediately after the end of the methotrexate infusions, and consisted of 8 g/sq m/day for 3 days or until serum methotrexate was below a toxic level. Mucositis and myelosuppression were the major toxicities. Neither was dose related. Serum methotrexate levels were proportional to the logarithm of the methotrexate dose. There was a mean 6-fold increase in thymidine concentration during rescue. However, thymidine levels prior to and during rescue were not related to the incidence of subsequent toxicity. Recovery of DNA synthesis in bone marrow cells was evident by nucleoside precursor incorporation at 24 hr after the start of rescue. Two of 16 evaluable patients achieved partial responses. This study indicates that thymidine is an effective rescue agent for high-dose methotrexate in humans.",
author = "Howell, {S. B.} and Ensminger, {W. D.} and A. Krishan and E. Frei",
year = "1978",
month = "1",
day = "1",
language = "English",
volume = "38",
pages = "325--330",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Thymidine rescue of high-dose methotrexate in humans

AU - Howell, S. B.

AU - Ensminger, W. D.

AU - Krishan, A.

AU - Frei, E.

PY - 1978/1/1

Y1 - 1978/1/1

N2 - Thymidine rescue was administered following 63 courses of high dose methotrexate in 20 patients. In the first part of this study, the methotrexate was given as a 24-hr infusion and the dose was escalated from 0.14 to 8.54 g/sq m; in the second part, methotrexate was infused to maintain a serum concentration of 15 μM for 30, 36, or 40 hr. Thymidine rescue was started immediately after the end of the methotrexate infusions, and consisted of 8 g/sq m/day for 3 days or until serum methotrexate was below a toxic level. Mucositis and myelosuppression were the major toxicities. Neither was dose related. Serum methotrexate levels were proportional to the logarithm of the methotrexate dose. There was a mean 6-fold increase in thymidine concentration during rescue. However, thymidine levels prior to and during rescue were not related to the incidence of subsequent toxicity. Recovery of DNA synthesis in bone marrow cells was evident by nucleoside precursor incorporation at 24 hr after the start of rescue. Two of 16 evaluable patients achieved partial responses. This study indicates that thymidine is an effective rescue agent for high-dose methotrexate in humans.

AB - Thymidine rescue was administered following 63 courses of high dose methotrexate in 20 patients. In the first part of this study, the methotrexate was given as a 24-hr infusion and the dose was escalated from 0.14 to 8.54 g/sq m; in the second part, methotrexate was infused to maintain a serum concentration of 15 μM for 30, 36, or 40 hr. Thymidine rescue was started immediately after the end of the methotrexate infusions, and consisted of 8 g/sq m/day for 3 days or until serum methotrexate was below a toxic level. Mucositis and myelosuppression were the major toxicities. Neither was dose related. Serum methotrexate levels were proportional to the logarithm of the methotrexate dose. There was a mean 6-fold increase in thymidine concentration during rescue. However, thymidine levels prior to and during rescue were not related to the incidence of subsequent toxicity. Recovery of DNA synthesis in bone marrow cells was evident by nucleoside precursor incorporation at 24 hr after the start of rescue. Two of 16 evaluable patients achieved partial responses. This study indicates that thymidine is an effective rescue agent for high-dose methotrexate in humans.

UR - http://www.scopus.com/inward/record.url?scp=0017797163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017797163&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 325

EP - 330

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 2

ER -